Janus Henderson Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.41M Buy
226,000
+10,600
+5% +$259K ﹤0.01% 933
2025
Q4
$4.87M Hold
215,400
﹤0.01% 948
2025
Q3
$4.34M Hold
215,400
﹤0.01% 965
2025
Q2
$3.08M Hold
215,400
﹤0.01% 1097
2025
Q1
$2.24M Sell
215,400
-12,000
-5% -$136K ﹤0.01% 1216
2024
Q4
$2.75M Sell
227,400
-8,600
-4% -$113K ﹤0.01% 1149
2024
Q3
$3.47M Hold
236,000
﹤0.01% 1036
2024
Q2
$3.4M Sell
236,000
-2,521
-1% -$40.3K ﹤0.01% 1004
2024
Q1
$3.88M Sell
238,521
-12
-0% -$188 ﹤0.01% 977
2023
Q4
$3.56M Sell
238,533
-463
-0.2% -$5.24K ﹤0.01% 961
2023
Q3
$2.69M Sell
238,996
-21,482
-8% -$249K ﹤0.01% 1036
2023
Q2
$2.62M Sell
260,478
-4,616,159
-95% -$42.8M ﹤0.01% 1111
2023
Q1
$45.8M Sell
4,876,637
-7,101,218
-59% -$83.8M 0.03% 397
2022
Q4
$146M Sell
11,977,855
-12,135,537
-50% -$151M 0.1% 194
2022
Q3
$299M Buy
24,113,392
+12,151,843
+102% +$212M 0.11% 189
2022
Q2
$235M Sell
11,961,549
-350,322
-3% -$8.29M 0.16% 153
2022
Q1
$321M Buy
12,311,871
+715,654
+6% +$19.1M 0.16% 154
2021
Q4
$329M Sell
11,596,217
-586,244
-5% -$18.2M 0.14% 168
2021
Q3
$388M Sell
12,182,461
-7,029,791
-37% -$236M 0.17% 137
2021
Q2
$666M Sell
19,212,252
-8,944,436
-32% -$295M 0.29% 87
2021
Q1
$829M Sell
28,156,688
-6,710,380
-19% -$206M 0.38% 59
2020
Q4
$1.07B Sell
34,867,068
-1,014,177
-3% -$30.9M 0.5% 35
2020
Q3
$1B Buy
35,881,245
+2,449,102
+7% +$62.1M 0.52% 36
2020
Q2
$717M Buy
33,432,143
+2,643,285
+9% +$58.4M 0.4% 47
2020
Q1
$689M Buy
30,788,858
+20,846,120
+210% +$571M 0.47% 40
2019
Q4
$293M Buy
9,942,738
+2,885,708
+41% +$78.4M 0.15% 158
2019
Q3
$188M Sell
7,057,030
-113,481
-2% -$3.4M 0.1% 212
2019
Q2
$242M Sell
7,170,511
-1,108,234
-13% -$36M 0.13% 183
2019
Q1
$265M Buy
8,278,745
+6,546,483
+378% +$201M 0.15% 172
2018
Q4
$54.6M Sell
1,732,262
-244,654
-12% -$8.01M 0.03% 513
2018
Q3
$69M Buy
+1,976,916
New +$69.5M 0.04% 495

Other funds holding ELAN